Table 4. Prostate cancer mortality by arm, with mortality reduction and number needed to invite by ERSPC center.
CENTER | Cumulative PC mortality, % | Mortality reduction | Number needed to invite | Number needed to detect | |
---|---|---|---|---|---|
Screening, Ms | Control, Mc | (Mc-Ms), % | (1/mortality reduction)* | (NNI/NNO)# | |
The Netherlands | 0.49 | 0.72 | 0.24 | 422 (253-1381) | 27 |
Belgium | 0.42 | 0.54 | 0.12 | 816 (243 – ND) | 18 |
Sweden | 0.64 | 1.04 | 0.40 | 252 (140-1534) | 12 |
Finland | 0.53 | 0.59 | 0.05 | 1821 (631 – ND) | 37 |
Italy | 0.36 | 0.44 | 0.08 | 1198 (349 – ND) | 29 |
Spain | 0.19 | 0.35 | 0.16 | 621 (419 – ND) | 23 |
Switzerland | 0.32 | 0.28 | -0.04 | ND§ | ND§ |
Expressed as an integer, with rounding upward
No mortality reduction, NNI not meaningful
1Number needed to detect/number needed for overdiagnosis (1/mortality reduction : 1/excess incidence = excess incidence/mortality reduction)